Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126927352 | 12692735 | 2 | F | 20160823 | 20160829 | 20160906 | EXP | GB-MHRA-ADR 23597397 | GB-ACCORD-043429 | ACCORD | 0.00 | M | Y | 0.00000 | 20160906 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126927352 | 12692735 | 1 | PS | AMITRIPTYLINE | AMITRIPTYLINE | 1 | Oral | AT NIGHT | Y | 202446 | 20 | MG | QD | ||||||
| 126927352 | 12692735 | 2 | SS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | Y | 202553 | 10 | MG | QD | |||||||
| 126927352 | 12692735 | 3 | SS | ATENOLOL/ATENOLOL HYDROCHLORIDE | ATENOLOL HYDROCHLORIDE | 1 | Oral | Y | 200750042 | 25 | MG | QD | |||||||
| 126927352 | 12692735 | 4 | SS | PERINDOPRIL/PERINDOPRIL ERBUMINE | PERINDOPRIL ERBUMINE | 1 | Oral | Y | 200750294 | 8 | MG | QD | |||||||
| 126927352 | 12692735 | 5 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 126927352 | 12692735 | 6 | C | ATORVASTATIN/ATORVASTATIN CALCIUM | 2 | 0 | |||||||||||||
| 126927352 | 12692735 | 7 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | 0 | ||||||||||||
| 126927352 | 12692735 | 8 | C | CODEINE | CODEINE | 1 | 0 | ||||||||||||
| 126927352 | 12692735 | 9 | C | GLYCERYL TRINITRATE | NITROGLYCERIN | 1 | 0 | ||||||||||||
| 126927352 | 12692735 | 10 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 0 | ||||||||||||
| 126927352 | 12692735 | 11 | C | LOPERAMIDE | LOPERAMIDE | 1 | 0 | ||||||||||||
| 126927352 | 12692735 | 12 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | 0 | ||||||||||||
| 126927352 | 12692735 | 13 | C | PARACETAMOL | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 126927352 | 12692735 | 14 | C | QUINIDINE | QUINIDINE | 1 | 0 | ||||||||||||
| 126927352 | 12692735 | 15 | C | SALBUTAMOL/SALBUTAMOL SULFATE | 2 | 0 | |||||||||||||
| 126927352 | 12692735 | 16 | C | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 0 | ||||||||||||
| 126927352 | 12692735 | 17 | C | SULFASALAZINE. | SULFASALAZINE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126927352 | 12692735 | 1 | Product used for unknown indication |
| 126927352 | 12692735 | 2 | Product used for unknown indication |
| 126927352 | 12692735 | 3 | Product used for unknown indication |
| 126927352 | 12692735 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126927352 | 12692735 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126927352 | 12692735 | Fall | |
| 126927352 | 12692735 | Orthostatic hypotension |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |